Abbott makes pharmaceuticals, diagnostic tests, nutritional products, and medical devices for healthcare providers and consumers. It last closed at $104.76 on Nov 17, down 2.50% on the day. ABT reports earnings on Thu, Jan 28, 2027. The average 12-month price target from 9 analysts is $122.00 (+16.5% from the last close), with a high of $127.00 and a low of $118.00. Analyst consensus is Strong Buy, based on the latest ratings from 9 firms (9 buy, 0 hold, 0 sell). Over the past 90 days StreetAlpha recorded 5 whale options trades in ABT, 40% of them bullish and 60% bearish. In the past 30 days there were 19 dark pool prints totaling $31.4M, the largest $5.5M.
Each firm's latest rating on ABT in the past 90 days
Average 12-month target
$122.00
▲ 16.5% upside
Based on 9 analysts who set a price target on ABT in the past 90 days. The average target is $122.00, with a high of $127.00 and a low of $118.00, compared with the last close of $104.76.
Highest target$127.00
Average target$122.00
Lowest target$118.00
Latest rating changes
Wells FargoTarget raised
Oct 23Buy$119 → $120
CitigroupTarget raised
Oct 22Buy$112 → $122
RBC CapitalMaintained
Oct 22Buy$125
Wells FargoTarget raised
Oct 22Buy$112 → $119
JP MorganTarget lowered
Oct 22Buy$120 → $118
Date
Firm
Action
Rating
Price target
Oct 23
Wells Fargo
Target raised
Buy
$119 → $120
Oct 22
Citigroup
Target raised
Buy
$112 → $122
Oct 22
RBC Capital
Maintained
Buy
$125
Oct 22
Wells Fargo
Target raised
Buy
$112 → $119
Oct 22
JP Morgan
Target lowered
Buy
$120 → $118
Loading…
Technical Analysis
ABT · as of the Nov 17 close · updated after every close
Moving sideways
The stock sits between its 20 and 50 day averages. It is 3% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 46). The nearest support is the 100 day average at $104.24, and the nearest resistance the Pivot at $105.84.
Short trendNeutral
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 2.9%/day
Key levels
$132.0352 week high+26.0%
$107.2520 day average+2.4%
$107.10Pivot R1+2.2%
$106.35Swing high (Oct 21)+1.5%
$105.84Pivot+1.0%
$104.76Last close
$104.24100 day average−0.5%
$103.8850 day average−0.8%
$103.50Pivot S1−1.2%
$102.89Swing low (Jul 31)−1.8%
$101.52200 day average−3.1%
$81.9752 week low−21.8%
Indicators
RSI (14)
45.61
Middle of its range
Neutral
MACD
1.14
Below its signal line
Bearish
Stochastic
31.8
Middle of its range
Neutral
ADX (14)
18.9
No clear trend
Williams %R
-87.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-28.6
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.2%
Change over 10 sessions
Bearish
ATR (14)
$3.00
Typical daily range, 2.9% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityHigh, 5.9%/day
Key levels
$132.0352 week high+26.0%
$107.2520 day average+2.4%
$107.10Pivot R1+2.2%
$106.35Swing high (Oct 21)+1.5%
$105.84Pivot+1.0%
$104.76Last close
$104.24100 day average−0.5%
$103.8850 day average−0.8%
$103.50Pivot S1−1.2%
$102.89Swing low (Jul 31)−1.8%
$101.52200 day average−3.1%
$81.9752 week low−21.8%
Indicators
RSI (14)
50.75
Middle of its range
Neutral
MACD
0.89
Above its signal line
Bullish
Stochastic
56.9
Middle of its range
Neutral
ADX (14)
17.6
No clear trend
Williams %R
-56.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
25.4
Oversold below −100, overbought above 100
Neutral
Rate of change
+2.8%
Change over 10 sessions
Bullish
ATR (14)
$6.16
Typical daily range, 5.9% of price
MA 10Above
MA 20Below
MA 50Above
MA 100Below
MA 200–
What happened before, for ABT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how ABT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow leans bearish2 bullish and 3 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow ABT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How ABT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
FLEX options are customized, exchange-listed contracts used mostly by institutions. StreetAlpha scans the daily FLEX report for unusually large, long-dated positions. Multi-leg structures, such as paired calls and puts used for financing or hedging, are listed but not counted in these totals.
For membersMonth by month buying, shares and the average price paid each month are shown to AI Starter and AI Pro members.
From the company's 10-Q filed Nov 4, 2026. Quarters are the company's own fiscal quarters. Yield and % of value use the latest close. Buybacks are not a forecast: in our testing, the biggest buyers did about the same as the average S&P 500 stock.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ABT is in one of them and how their past ABT trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Abbott Laboratories
Abbott is a health care company based in Abbott Park, Illinois. It develops, makes, and sells products in four main areas: established pharmaceutical products, diagnostic systems and tests, nutritional products, and medical devices. Its customers include hospitals, clinics, laboratories, pharmacies, wholesalers, healthcare providers, government agencies, and consumers, and it sells in markets around the world.